Some bacteria produce antimicrobial chemicals in their immediate environments. These antimicrobial agents are enzymes, polypeptides or non-protein organic compounds. In this study, a bacterial isolate that produces antifungal chemical(s) was isolated from an over incubated nutrient agar plate that was exposed to air. The bacterium is aerobic, Gram positive bacilli; capsule and endospore producing. It ferments glucose and sucrose but not lactose, galactose, mannitol and sorbitol; it is citrate, indole, methyl red and Voges Prauskauer negative. Using agar gel diffusion technique, the cell-free culture supernatant resulting from centrifugation of a six day bacterial culture showed antifungal activity against filamentous fungi but not yeasts. Heating the cell-free supernatant in 90 ˚C water bath and digestion with different proteases had no negative impact on the antifungal activity. A segment of 16S rRNA gene of the bacterial isolate was amplified. The nucleotide sequence of the amplicon was used to identify the bacterium as being very similar to Bacillus amyloliquefaciens subsp. plantarum strain FZB42. Five bacterial peptides were isolated and identified from cell free supernatant of the bacterial culture using a suite of techniques, including flash chromatography, HPLC, NMR and mass spectrometry. One of the five peptides has been previously reported in literature to possess antifungal activity.
INTRODUCTION
. Most of the purified antifungal agents in the studies are polypeptides; some are chitinolytic enzymes while others are non-protein compounds, each with different properties. Such antifungal agents have potential uses in agriculture where they could serve as alternatives to chemical fungicides that are used to prevent plant fungal diseases of agricultural products and plants. Purified antifungal agents also have potential uses in cell culture and as food preservatives. In the current study, nutrient agar plates were exposed to air and incubated at room temperature. One of these plates was overgrown with a filamentous fungus except around a bacterial colony where there was inhibition of fungal growth (Figure 1) . The aims of this study are to characterize and identify the antifungal bacterial isolate and also the antifungal chemical produced by the bacterial isolate. 
MATERIALS AND METHODS

Initial screening of efficacy of bacterial antifungal activity
The antifungal bacterium was subcultured on LB agar to obtain a pure culture. The efficacy of the bacterial isolate on fungal growth was done using agar diffusion method. Sabouraud dextrose agar plates were prepared and separate plates were inoculated with a wild yeast, Candida albicans and different types of filamentous fungi; the plates were incubated at 25 C. When fungal growth was evident on each of the plates, the bacterial isolate was then inoculated approximately one inch directly opposite the fungal growth; the plates were incubated further.
Some bacteria produce antimicrobial chemicals in their immediate environments. These antimicrobial agents are enzymes, polypeptides or non-protein organic compounds. In this study, a bacterial isolate that produces antifungal chemical(s) was isolated from an over incubated nutrient agar plate that was exposed to air. The bacterium is aerobic, Gram positive bacilli; capsule and endospore producing. It ferments glucose and sucrose but not lactose, galactose, mannitol and sorbitol; it is citrate, indole, methyl red and Voges Prauskauer negative. Using agar gel diffusion technique, the cell-free culture supernatant resulting from centrifugation of a six day bacterial culture showed antifungal activity against filamentous fungi but not yeasts. Heating the cell-free supernatant in 90 ˚C water bath and digestion with different proteases had no negative impact on the antifungal activity. A segment of 16S rRNA gene of the bacterial isolate was amplified. The nucleotide sequence of the amplicon was used to identify the bacterium as being very similar to Bacillus amyloliquefaciens subsp. plantarum strain FZB42. Five bacterial peptides were isolated and identified from cell free supernatant of the bacterial culture using a suite of techniques, including flash chromatography, HPLC, NMR and mass spectrometry. One of the five peptides has been previously reported in literature to possess antifungal activity.
Characterization of bacterial antifungal chemical
The bacterial isolate was inoculated into 500 ml of LB broth and incubated at 25 ˚C in a shaker incubator. Cell free supernatant was obtained by centrifugation of the culture in a Beckman Model J2-21centrifuge using JA 14 rotor. The supernatant was further filtered using 0.45µM Nalgene disposable membrane filter ware. The resulting cell-free supernatant was stored at 4 C. Antifungal activity of the supernatant was determined using agar gel diffusion method. The effect of temperature on the efficacy of the antifungal agent was carried out by incubating the cell-free supernatant at 40 ˚C, 50 ˚C, 70 ˚C and 90 ˚C for 30 minute. This was followed by efficacy test against filamentous fungus using agar gel diffusion. Effect of enzyme treatment on the antifungal agent was done. The enzymes used were lipase, protease, proteinase K, pepsin and chymotrypsin. Culture supernatant was subjected to enzyme treatments for 1hr in a 37 ˚C water bath after which the enzyme was inactivated prior to determining the efficacy of the product on fungal growth. Efficacy was determined using agar gel diffusion method as stated earlier.
Morphological and biochemical characterization of the antifungal agentproducing bacterial isolate
Morphological characteristics of the bacterial isolate were determined using routine microbiological tests including Gram stain, endospore stain, capsule stain and motility test. Biochemical characterization of the bacterial isolate included the following tests: fermentation of different sugars, catalase production, oxidase test, MR-VP test, oxygen requirement test using fluid thioglycollate broth, indole production, citrate utilization, and production of exoenzymes for hydrolysis of starch, protein and lipid. All the microbiological tests were performed as are described by Leboffe and Pierce (2008).
Identification of bacterial isolate
The bacterial isolate was identified by amplification and sequencing of segment of 16S rRNA gene using colony PCR and universal primers F-27 5'-AGAGTTTGATCMTGGCTCAG-3' and R1525 5'-AAGGAGGTGWTCCARCC-3'. The PCR conditions were denaturation at 94 ˚C for 5 min; 30 cycles: 94 ˚C for 30 sec, 55 ˚C for 30 sec, 72 ˚C for 1.5 min; final extension at 72 ˚C for 10 min. The PCR product was cloned into TA cloning vector following the manufacturer's protocol; this was followed by transformation.
Recombinant plasmids were prepared from selected transformants using Qiagen Mini Plasmid Preparation kit and were quantitated using NanoDrop Spectrophotometer, ND-1000. DNA sequencing was done by Integrated DNA Technologies, Inc. The nucleotide sequence obtained was used to identify the bacterial isolate using the National Center for Biotechnology Information (NCBI) genomic BLAST.
Purification of antifungal metabolites
An extraction of the cell-free supernatant was performed by adding CHCl3-CH3OH (4:1). The mixture was stirred for 30 min and then transferred to a separating funnel. The bottom layer was drawn off and evaporated to dryness. The resulting organic component was further extracted with equal volume of CH3OH-CH3CN and hexanes; the two layers were drawn off, evaporated to dryness under vacuum and the dried extracts were weighed. This was followed by flash chromatography of the CH3OH-CH3CN extract. The extract was dissolved in CHCl3 and transferred onto celite and allowed to dry. The celite was transferred and packed in a chromatography cartridge. At a 18 mL/min flow rate, a solvent gradient of 100% hexane to 100% CHCl3 to 100% CH3OH was flowed through the chromatography cartridge over 28 min. The sample was pooled into three fractions and evaporated to dryness. Fraction 2 was dissolved in 1:1 CH3OH-dioxane and subjected to preparative HPLC. The mobile phase was a gradient of CH3CN-H2O with 0.1% formic acid. The gradient flowed at 15-20% CH3CN over 15 min to 20% isocratic CH3CN over 20 min at a 15 mL/min flow rate. The column used was an Atlantis Prep, OBD 19x250 mm column, No. 186004026. This yielded five isolated compounds.
Identification of antifungal metabolites
High resolution mass spectrometry (HRMS) was performed using a QExactive Plus (Thermo Fisher Scientific, San Jose, CA, USA). Resolution was 70,000, and MS/MS was performed with higher energy collisional dissociation (HCD) at 52.50. Additionally, the 1 H NMR (400 MHz; JEOL Ltd., Tokyo, Japan) was performed on the isolated compounds to confirm the structures.
RESULTS
Screening and characterization of antifungal metabolite
Streak of the bacterial isolate opposite Candida albicans and filamentous fungi showed that the antifungal metabolite secreted into the culture medium inhibited only filamentous fungi. Figure 2 shows inhibition of a filamentous fungus by the bacterial isolate after incubation of the plate for four days. Cell-free supernatant obtained from centrifugation of the antifungal bacterial isolate in LB broth also showed growth inhibition of filamentous fungi (Figure 3) . The results of heat treatment of the cell-free, culture supernatant showed that the antifungal metabolite is heat stable because the efficacy of the culture supernatant was not abrogated by the treatments (Figure 4) . Treatment of the cell-free supernatant with the enzymes used in the studies produced no negative effect on the efficacy against filamentous fungi. Inhibition of fungal growth opposite wells filled with cell-free culture supernatants (heated at 95 ˚C for 30 min and untreated control "C"). The plate was incubated at room temperature for more than 8 days during which the supernatants in the two wells were replenished several times. At the bottom of the plate is not a well but an accidental agar chip.
Morphological and biochemical characterization of antifungal bacterial isolate
The results of morphological and biochemical tests of the bacterial isolate are shown in Table I . The biochemical tests were carried out after approximately 24 -48 hour incubation. 
Identification of bacterial isolate.
A segment of 16S rRNA was amplified using universal primers F21 and R1525. The nucleotide sequence (1541 nucleotides) of the amplified segment of 16S rRNA gene of the bacterial isolate is shown in Figure 5 . The DNA sequence was compared with NCBI gene bank database using BLAST algorithm. The result showed a 99% homology of the search sequence with Bacillus amyloliquefaciens subsp. plantarum strain FZB42. The nucleotide sequence was deposited in GenBank under accession number SUB1340497 AF-1 KU738862. 
Purification and identification of antifungal metabolites
The CHCl3-CH3OH extract from the cell-free supernatant yielded 280 mg. Flash chromatography on this extract produced three fractions that weighed 0.20 mg, 19 mg and 220 mg. While fraction three had the largest yield, analytical HPLC revealed that it primarily contained sugars not shown). Therefore only fraction 2 was pursued further, which led to the isolation of compounds 1-5. These compounds were tentatively identified using high resolution and tandem mass spectrometry ( Table 2 ). The structures of the compounds were then confirmed using 1 H NMR (Figures S1 {Supplement 1} through S5 {Supplement 5}). All of the isolated compounds were small cyclic peptides (Figure 6) ; the characterization data for each compound were in good agreement with the literature ( 195.1128 195.1128 195, 98, 70 _________________________________________________________________ 2 197.1284 197.1285 197, 169, 154, 141, 124, 100, 98, 72, 70 _________________________________________________________________ 3 211.1440 211.1441 211, 183, 154, 138, 114, 98, 86, 70 _________________________________________________________________ 4 211.1440 211.1441 211, 183, 154, 138, 114, 98, 86, 70 _________________________________________________________________ 5 245.1284 245.1285 245, 217, 172, 154, 120, 98 , 70 ________________________________________________________________ . In their study, Munimbazi and Bullerman (1998) reported that an isolate of Bacillus pumilus from a sample of dried fish was the source of an antifungal agent. Two different studies showed that Bacillus amyloliquefaciens GAI (Arguelles-Arias et al., 2009) and Bacillus amyloliquefaciens LJ02 (Li et al., 2015) produced secondary metabolites for the biocontrol of plant pathogen and for cucurbits powdery mildew, respectively. The antifungal activity of B. amyloliquefaciens GAI was due to cyclic lipopeptides surfactin, iturin A and fengycin. The antifungal agent produced by the bacterial isolate, Bacillus amyloliquefaciens subsp. plantarum strain FZB42, in the current study is similar to that produced by B. pumilus (Munimbazi and Bullerman, 1998) in their inhibitory effect on filamentous fungi and not yeasts, resistance to heat treatment and resistance to denaturation by hydrolytic enzymes. However, unlike the current study where the bacterial antifungal agent was isolated and identified, Munimbazi and Bullerman did not identify the antifungal agent. In this study, five cyclic dipeptides were isolated from cell-free, culture supernatant of Bacillus amyloliquefaciens subsp. plantarum strain FZB42. The five peptides were identified as: cis-Cyclo(L-Pro-L-Pro) (1), cis-Cyclo(L-Pro-L-Val) (2), cisCyclo(L-Pro-L-Ile) (3), cis-Cyclo(L-Pro-L-Leu) (4) and cis-Cyclo(L-Pro-L-Phe) (5). This report that cyclic peptide is responsible for antifungal activity the bacterial isolate is supported by Magnusson et al. (2003) ; the group reported that the antifungal activity of Lactobacillus coryniformis strain Si3 could be due to Cyclo(phe-Pro) and Cyclo(Phe-4-OH-Pro) that were identified from bacterial culture supernatant. While one of these five peptides, cis-Cyclo(L-Pro-L-Val) (2) in the current study was previously reported to have an antifungal effect, the roles of the other four metabolites are not exactly known. Purified antifungal peptides could be a better alternative to the use of whole bacterial cells as inhibitors of fungal phytopathogens. The biological active, antifungal peptide could also find uses in the food industries as preservatives, in cell culture and in treating human dermatophytes.
CONCLUSION
It can be concluded that this study supports previous findings that members of the genus Bacillus produce antifungal agents. The bacterial isolate that was identified as Bacillus amyloliquefaciens subspecies plantarum strain FZB42 produces five peptide metabolites; at least one of these peptide metabolites (cis-Cyclo(L-Pro-LVal) is a known and unique antifungal agent that is resistant to high temperature and hydrolytic enzymes. Future work is to synthesize: cis-Cyclo(L-Pro-L-Pro) (1), cis-Cyclo(L-Pro-L-Ile) (3), cis-Cyclo(L-Pro-L-Leu) (4) and cis-Cyclo(L-Pro-L-Phe) (5) and study their efficacy against fungi and bacteria.
